Liposomal Bupivacaine vs Adductor Canal Block in Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Knee Osteoarthritis

Interventions

DRUG

liposomal bupivacaine

DRUG

bupivacaine HCl

DRUG

Ropivacaine

DRUG

Saline

Trial Locations (1)

Texas Orthopedics, Austin

All Listed Sponsors

lead

Texas Orthopaedics, Sports and Rehabilitation Associates

OTHER

NCT02863120 - Liposomal Bupivacaine vs Adductor Canal Block in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter